Radiation boost may extend life for bladder cancer patients with few remaining tumors
NCT ID NCT04428554
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding focused radiation to standard treatment helps people with metastatic bladder cancer live longer. It includes patients whose cancer has not worsened after initial therapy and who have three or fewer remaining tumors. About 130 participants will be randomly assigned to receive either standard care alone or standard care plus radiation, and will be followed for up to four years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU Brest
RECRUITINGBrest, France
-
CHU Besançon
RECRUITINGBesançon, France
-
Centre Antoine Lacassagne
RECRUITINGNice, France
-
Centre Francois Baclesse
RECRUITINGCaen, France
-
Centre Jean Perrin
WITHDRAWNClermont-Ferrand, France
-
Centre Oscar Lambret
WITHDRAWNLille, France
-
Clinique Claude Bernard
RECRUITINGAlbi, France
-
Clinique Pasteur-Lanroze
RECRUITINGBrest, France
-
Groupe Hospitalier Paris Saint-Joseph
NOT_YET_RECRUITINGParis, France
-
Groupement de Radiothérapie et d'Oncologie des Pyrénées
WITHDRAWNPau, France
-
HIA Bégin
RECRUITINGSaint-Mandé, France
-
Institut Andrée Dutreix
RECRUITINGDunkirk, France
-
Institut Bergonie
RECRUITINGBordeaux, France
-
Institut Curie
RECRUITINGParis, France
-
Institut Gustave Roussy
RECRUITINGVillejuif, France
-
Institut Paoli-Calmettes
RECRUITINGMarseille, France
-
Institut Universitaire du Cancer Toulouse Oncopole
RECRUITINGToulouse, France
-
Institut de Cancerologie Lucien Neuwirth
NOT_YET_RECRUITINGSaint-Priest-en-Jarez, France
-
Institut de Cancerologie de L'Ouest
RECRUITINGAngers, France
-
Institut de Cancerologie de L'Ouest
RECRUITINGSaint-Herblain, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New Bladder-Sparing combo aims to avoid surgery in cancer patients
- Bladder cancer diagnosis: could a simple MRI replace painful biopsies?
- New vaccine combo shows promise in advanced cancers
- New drug targets Hard-to-Treat cancers in early trial
- Cancer drug combo trial halted early – what we know
- Cancer combo trial halted early – what went wrong?